Towards responsible use of cognitive-enhancing drugs by the healthy

Henry Greely; Barbara Sahakian; John Harris; Ronald C. Kessler; Michael Gazzaniga; Philip Campbell; Martha J. Farah

doi:10.1038/456702a

journal article Dec 10, 2008

Towards responsible use of cognitive-enhancing drugs by the healthy

Henry Greely Barbara Sahakian John Harris Ronald C. Kessler

Michael Gazzaniga Philip Campbell Martha J. Farah

Nature Vol. 456 No. 7223 pp. 702-705 · Springer Science and Business Media LLC

View at Publisher Save 10.1038/456702a

Topics

No keywords indexed for this article. Browse by subject →

References

23

[1]

McCabe, S. E., Knight, J. R., Teter, C. J. & Wechsler, H. Addiction 100, 96–106 (2005). 10.1111/j.1360-0443.2005.00944.x

[2]

Maher, B. Nature 452, 674–675 (2008). 10.1038/452674a

[3]

Sahakian, B. & Morein-Zamir, S. Nature 450, 1157–1159 (2007). 10.1038/4501157a

[4]

Weyandt, L. L & DuPaul, G. J. Atten. Disord. 10, 9–19 (2006). 10.1177/1087054705286061

[5]

Minzenberg, M. J. & Carter, C. S. Neuropsychopharmacology 33, 1477–1502 (2008). 10.1038/sj.npp.1301534

[6]

Vastag, B. J. Am. Med. Assoc. 291, 167–170 (2004). 10.1001/jama.291.2.167

[7]

Turner, D. C. et al. Psychopharmacology 165, 260–269 (2003). 10.1007/s00213-002-1250-8

[8]

Grön, G., Kirstein, M., Thielscher, A., Riepe, M. W. & Spitzer, M. Psychopharmacology 182, 170–179 (2005). 10.1007/s00213-005-0043-2

[9]

Lynch, G. & Gall C. M. Trends Neurosci. 29, 554–562 (2006). 10.1016/j.tins.2006.07.007

[10]

Hillman, C. H., Erikson, K. I. & Kramer, A. F. Nature Rev. Neurosci. 9, 58–65 (2008). 10.1038/nrn2298

[11]

Almeida, S. S. et al. Nutr. Neurosci. 5, 311–320 (2002). 10.1080/1028415021000033776

[12]

Boonstra, T. W., Stins, J. F., Daffertshofer, A. & Beek, P. J. Cell. Mol. Life Sci. 64, 934–946 (2007). 10.1007/s00018-007-6457-8

[13]

Draganski, B. et al. Nature 427, 311–312 (2004). 10.1038/427311a

[14]

Development of Neural Systems for Reading

Bradley L. Schlaggar, Bruce D. McCandliss

Annual Review of Neuroscience 2007 10.1146/annurev.neuro.28.061604.135645

[15]

Farah, M. J. et al. Nature Rev. Neurosci. 5, 421–425 (2004). 10.1038/nrn1390

[16]

Kass, L. R. et al. Beyond Therapy: Biotechnology and the Pursuit of Happiness (President's Council on Bioethics, 2003); available at http://www.bioethics.gov/reports/beyondtherapy .

[17]

Harris, J. Enhancing Evolution: The Ethical Case for Making Better People (Princeton Univ. Press, 2007).

[18]

Schacter, D. L. Seven Sins of Memory (Houghton Mifflin, 2002).

[19]

Moreno, J. D. Mind Wars: Brain Research and National Defense (Dana Press, 2006).

[20]

Diller, L. H. Hastings Cent. Rep. 26, 12–18 (1996). 10.2307/3528571

[21]

Fukuyama, F. Our Posthuman Future: Consequences of the Biotechnology Revolution (Farrar, Straus and Giroux, 2002).

[22]

Chatterjee, A. Neurology 63, 968–974 (2004). 10.1212/01.wnl.0000138438.88589.7c

[23]

Beddington, J. et al. Nature 455, 1057–1060 (2008). 10.1038/4551057a

Cited By

590

Dissociative Effects of Methylphenidate in Nonhuman Primates: Trade-offs between Cognitive and Behavioral Performance

Abigail Z. Rajala, Jeffrey B. Henriques · 2012

Journal of Cognitive Neuroscience

Metrics

590

Citations

23

References

Details

Published: Dec 10, 2008
Vol/Issue: 456(7223)
Pages: 702-705
License: View

Authors

Dr. Costello is with the Department of Psychiatry, Duke University, Durham, North Carolina (e-mail: ). Ms. He is with the Division of Intramural Research Programs and Dr. Merikangas is with the Mood and Anxiety Disorders Program, Section on Developmental Genetic Epidemiology, both at the National Institute of Mental Health, Bethesda, Maryland. Ms. Sampson and Dr. Kessler are with the Department of Health Care Policy, Harvard Medical School, Boston.

Cite This Article

Henry Greely, Barbara Sahakian, John Harris, et al. (2008). Towards responsible use of cognitive-enhancing drugs by the healthy. Nature, 456(7223), 702-705. https://doi.org/10.1038/456702a

Towards responsible use of cognitive-enhancing drugs by the healthy

You May Also Like